Quotes 5-day view Real-time Euronext Paris
05/22/2023
05/23/2023
05/24/2023
05/25/2023
05/26/2023
Date
100.7(c)
98.86(c)
96.04(c)
96.52(c)
95.56(c)
Last
99 769
116 663
87 181
75 349
126 680
Volume
-0.54%
-1.83%
-2.85%
+0.50%
-0.99%
Change
Estimated financial data (e) EUR USD
Sales 2023
3 713 M
3 974 M
3 974 M
Net income 2023
444 M
475 M
475 M
Net cash position 2023
379 M
405 M
405 M
P/E ratio 2023
26,0x
Yield 2023
0,79%
Sales 2024
3 917 M
4 193 M
4 193 M
Net income 2024
493 M
528 M
528 M
Net cash position 2024
643 M
689 M
689 M
P/E ratio 2024
23,4x
Yield 2024
0,83%
Capitalization
11 269 M
12 061 M
12 061 M
EV / Sales 2023
2,93x
EV / Sales 2024
2,71x
Nbr of Employees
12 846
Free-Float
36,7%
bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows:
- medical applications (84.7%): in industry, microbiological testing of samples from...
All news about BIOMÉRIEUX
News in other languages on BIOMÉRIEUX
Analyst Recommendations on BIOMÉRIEUX
BIOMÉRIEUX - 03/09
Good timing to go long again
BUY
ETFs positioned on BIOMÉRIEUX ETFs and Trackers with Trackinsight
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BIOMÉRIEUX
Short Term Mid-Term Long Term Trends Neutral Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
95,56 €
Average target price
105,75 €
Spread / Average Target
10,7%
Please enable JavaScript in your browser's settings to use dynamic charts.